Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.
about
Interventions for preventing non-melanoma skin cancers in high-risk groupsInterventions for basal cell carcinoma of the skinInterventions for the prevention of non-melanoma skin cancers in high-risk groupsInterventions for basal cell carcinoma of the skinNonsurgical innovations in the treatment of nonmelanoma skin cancerBasal cell carcinomaBasal cell carcinoma treated successfully with combined CO2 laser and photodynamic therapy in a renal transplant patient: a case report.Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.The effective treatment of basal cell carcinoma.The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.Presence of interferon regulatory factor-1 in aggressive and nonaggressive histological variants of Basal cell carcinoma specimens.Basal cell carcinoma of the head and neckCervical in-transit metastasis from a truncal basal cell carcinoma.Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?Basal cell carcinoma: a dermatopathological and molecular biological update.[Basal cell basal cell epithelioma of the face: surgical management, about 45 cases and review of the literature]Photodynamic therapy for the treatment of skin disease.Current treatment patterns in non-melanoma skin cancer across Europe.Interventions for basal cell carcinoma of the skin: systematic review.Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis.Molecular aetiology and pathogenesis of basal cell carcinoma.Surgical treatment of basal cell carcinomas using standard postoperative histological assessment.The small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer.Management of basal cell carcinoma by surveyed dermatologists in Scotland.The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities.Guidelines for the management of basal cell carcinoma.Pigmented Basal cell carcinoma: a clinical variant, report of two cases.Basal cell carcinoma: evidence-based medicine and review of treatment modalities.A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.Vismodegib: a promising drug in the treatment of basal cell carcinomas.Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor.Giant cell temporal arteritis associated with overlying basal cell carcinoma: co-incidence or connection?Linear Basal cell carcinoma in an asian patient.Audit of basal cell carcinoma: registration practice.Basal cell carcinoma workload in two district general hospitals.Weekly radiotherapy for basal cell carcinoma in the frail and elderly.Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe.
P2860
Q24242914-51BCBBCE-6B8B-409D-A3A2-2C68D7568A34Q24246327-9DEA6554-548E-4B88-89E0-7BCC3F746FFDQ24246798-1418EBEE-FA03-4BF5-A436-1485D530D67FQ24248724-A8E7F4E8-493F-4137-872C-09DE318C7B42Q24632006-3F0408E1-C33B-44BB-99B7-9A56DED71B0AQ24677030-F0E2769F-B25B-4556-B2B6-7B1DEA46C0FAQ30887187-26667A6B-36CE-4983-B8B8-1DF73A910337Q30975921-BE044744-4B86-4737-9EE3-37355D75C2B0Q33423843-176EAAEE-17C3-4A74-88BE-7EB042184E61Q33878766-17816495-75F8-4CD5-AAE8-4CD7821723D8Q33931680-081B34BE-E460-48FE-8D7D-265751FEF3F4Q34442671-35AE67A4-0260-4ECE-8A73-CF30612A7D05Q34525435-9FE39A38-2923-4C22-92CD-DCA7D054ECC8Q34609484-5F16ED84-7EB0-405E-A2DD-B99F26074505Q34680984-8CAC0F92-654C-4E5D-A323-BE1B7BC9639CQ35067052-C194C858-730A-4DEB-B980-80CDD545ED35Q35094528-480F32F2-2939-4205-BA15-F5F63FBF02D5Q35189332-3197564B-DACE-476E-9D0A-C972533A82F2Q35548847-02529BCD-3BB7-4FD3-B605-C311DFD5F7E2Q35886161-F43BEDE8-1B7C-4FDA-B875-DD026AF331EAQ35891714-84577C90-4355-4E1F-B266-024598EAB325Q36014865-68E4BBB5-839D-4DDB-897B-A09746F5765FQ36065271-E3DFCBBF-A20F-46D7-956B-AE72A8237407Q36158929-96AC223E-8690-4E6E-BB0A-5A8B52C16BE8Q36365397-CB4303DF-7FE4-4B11-87F0-73C174D958DAQ36379372-D56D8F9D-E7E5-4235-8F60-6D8BC62BDF81Q36562181-D6986BD8-B4E8-467D-B152-E6917368456FQ37162640-6FB8882B-EDC2-45DA-88F6-44D3429173FEQ37204336-98DA096A-5C20-4875-9A01-E8052A9ECF9EQ37573147-AF1AE184-4CB7-48C2-9564-880FEC203EB5Q37877283-BAC63E02-B7EC-44FC-AF5C-C30CACE5C654Q38859587-9DB6B0C4-12AA-4CF8-8394-A5F24B35AE6FQ39568979-A80A5266-EA8C-4C50-86A7-6FE143FCC937Q40493924-58C37883-5BCF-4C45-BCE7-A48EC6AD6FF3Q41871388-1ED2F4B8-DBEF-47C6-A22A-6E3EA7B6FA9EQ42163619-9EEC8B53-0E53-45E6-A63A-D919E8A41F8BQ42437133-06995551-7A1E-45D7-AC0F-98349FDF80B3Q42446934-33D7A33F-69C7-4A13-8380-7351F6385A7CQ42457713-104F092A-192C-4FD6-BC8E-F4BC767E2B5DQ42466491-1A835962-845F-489E-AD94-7570CEE0F81F
P2860
Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Guidelines for the management ...... Association of Dermatologists.
@en
Guidelines for the management ...... Association of Dermatologists.
@nl
type
label
Guidelines for the management ...... Association of Dermatologists.
@en
Guidelines for the management ...... Association of Dermatologists.
@nl
prefLabel
Guidelines for the management ...... Association of Dermatologists.
@en
Guidelines for the management ...... Association of Dermatologists.
@nl
P2093
P2860
P1476
Guidelines for the management ...... Association of Dermatologists.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.1999.03033.X
P407
P577
1999-09-01T00:00:00Z